Schlanger David J

About Schlanger David J

David J. Schlanger is a seasoned U.S. healthcare and digital health executive with a career defined by leadership, strategy, and growth-oriented transformation. At Progyny, Inc., he currently serves as Executive Chairman of the Board. He previously served as Progyny’s Chief Executive Officer from January 2017 through December 2021, after which he transitioned into a board-level leadership role focused on governance and strategic oversight. He has been a member of Progyny’s board since March 2017. His profile is closely associated with scaling healthcare businesses, building data-driven platforms, and guiding companies through periods of expansion. Before joining Progyny, Schlanger was Chief Executive Officer of WebMD from 2013 to 2016. During his tenure, WebMD delivered record revenue and profitability, and the audiences for both WebMD and Medscape grew to record highs. Prior to becoming CEO, he held a range of senior leadership roles at WebMD, including responsibility for strategy, mergers and acquisitions, and business development. Those positions helped shape a career built around corporate development, commercial execution, and long-term value creation. At Progyny, Schlanger’s leadership has been linked to the company’s growth in fertility and family-building benefits for employer clients, as well as to the continued development of a science-based, technology-enabled, and data-informed care model. His broader executive background suggests deep expertise in managing healthcare organizations, aligning product strategy with market demand, and supporting businesses as they scale in competitive sectors. He is widely characterized as a healthcare executive with substantial experience in digital health and benefits-related innovation. Schlanger earned a B.S. from Georgetown University and a J.D. from the University of Michigan Law School.